Team:Tokyo Tech
From 2013.igem.org
(Difference between revisions)
Line 22: | Line 22: | ||
<h4>[Fig. 1-1-1. Experiment workshop for human practice]<br> | <h4>[Fig. 1-1-1. Experiment workshop for human practice]<br> | ||
We assisted with an experiment workshop for high school students. | We assisted with an experiment workshop for high school students. | ||
- | |||
</h4> | </h4> | ||
</td> | </td> | ||
Line 44: | Line 43: | ||
<h4>[Fig. 1-1-3. Our designed circuit for circumvention of the crosstalk]<br> | <h4>[Fig. 1-1-3. Our designed circuit for circumvention of the crosstalk]<br> | ||
We designed the circumvention of the crosstalk by network engineering. | We designed the circumvention of the crosstalk by network engineering. | ||
- | |||
</h4> | </h4> | ||
</td> | </td> | ||
Line 58: | Line 56: | ||
<div align="center"><a href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay#1._Introduction"><img src="https://static.igem.org/mediawiki/2013/6/6f/Titech2013_home_Fig3_crosstalk_assay.png" width="120" height="200" style="border: #E7E5F0 2px"></a></div><br> | <div align="center"><a href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay#1._Introduction"><img src="https://static.igem.org/mediawiki/2013/6/6f/Titech2013_home_Fig3_crosstalk_assay.png" width="120" height="200" style="border: #E7E5F0 2px"></a></div><br> | ||
<h4>[Fig. 1-1-4. Result of our wet experiment for the circumvention of the crosstalk]<br>The level of GFP expression in cells where TetR is active is clearly lower than when TetR is inhibited. Even with activated LasR, <i>lux/tet</i> hybrid promoter is repressed by TetR precisely. This result suggest our | <h4>[Fig. 1-1-4. Result of our wet experiment for the circumvention of the crosstalk]<br>The level of GFP expression in cells where TetR is active is clearly lower than when TetR is inhibited. Even with activated LasR, <i>lux/tet</i> hybrid promoter is repressed by TetR precisely. This result suggest our | ||
- | network will circumvent the crosstalk by the activated LasR. | + | network will circumvent the crosstalk by the activated LasR. |
</h4><br> | </h4><br> | ||
Line 77: | Line 75: | ||
<h4>[Fig. 1-1-5. Our mathematical model for the circuit of <i>E. ninja</i>]<br> | <h4>[Fig. 1-1-5. Our mathematical model for the circuit of <i>E. ninja</i>]<br> | ||
The solid/dotted lines stand for the case with/without the crosstalk circumvention. The expression of LacI is repressed through the crosstalk circumvention. | The solid/dotted lines stand for the case with/without the crosstalk circumvention. The expression of LacI is repressed through the crosstalk circumvention. | ||
- | |||
</h4> | </h4> | ||
</td> | </td> | ||
Line 84: | Line 81: | ||
<td> | <td> | ||
<a href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/pSB-M13_Plasmid_Assay#1._Introduction"><img src="https://static.igem.org/mediawiki/2013/1/14/Titech2013_home_Fig6_M13_shuriken.png" width="240"></a><br> | <a href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/pSB-M13_Plasmid_Assay#1._Introduction"><img src="https://static.igem.org/mediawiki/2013/1/14/Titech2013_home_Fig6_M13_shuriken.png" width="240"></a><br> | ||
- | <h4>[Fig. 1-1-6. Our new part for inducible phage release]<br>We designed a new part for inducible phage release. Any promoter is allowed to be inserted upstream of <i>g2p</i> to regulate phage release. | + | <h4>[Fig. 1-1-6. Our new part for inducible phage release]<br>We designed a new part for inducible phage release. Any promoter is allowed to be inserted upstream of <i>g2p</i> to regulate phage release. |
</h4> | </h4> | ||
</td> | </td> | ||
<td> | <td> | ||
<a href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/Inducible_Plaque_Forming_Assay#1._Introduction"><img src="https://static.igem.org/mediawiki/2013/1/1e/Titech2013_M13_Plux_Fig_3-4-4-A.jpg" width="220"></a><br> | <a href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/Inducible_Plaque_Forming_Assay#1._Introduction"><img src="https://static.igem.org/mediawiki/2013/1/1e/Titech2013_M13_Plux_Fig_3-4-4-A.jpg" width="220"></a><br> | ||
- | <h4>[Fig. 1-1-7. Distribution of plaques and analysis] | + | <h4>[Fig. 1-1-7. Distribution of plaques and analysis] |
</td> | </td> | ||
<td> | <td> | ||
Line 108: | Line 105: | ||
<td> | <td> | ||
<a href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/Quantitative_Analysis_of_Cytokinin#1._Quantitative_analysis_of_cytokinins_using_cucumber_cotyledons"><img src="https://static.igem.org/mediawiki/2013/8/8a/Titech2013_home_Fig_1-1-7_cucumber.png" width="300"></a><br> | <a href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/Quantitative_Analysis_of_Cytokinin#1._Quantitative_analysis_of_cytokinins_using_cucumber_cotyledons"><img src="https://static.igem.org/mediawiki/2013/8/8a/Titech2013_home_Fig_1-1-7_cucumber.png" width="300"></a><br> | ||
- | <h4>[Fig. 1-1-8. Our bioassay of cucumber seed sprouts]<br>We cultivated the sprouts in standard cytokinin sample solutions and then measured the weight of the sprouts and the concentration of chlorophyll. | + | <h4>[Fig. 1-1-8. Our bioassay of cucumber seed sprouts]<br>We cultivated the sprouts in standard cytokinin sample solutions and then measured the weight of the sprouts and the concentration of chlorophyll. |
</h4> | </h4> | ||
</td> | </td> |
Revision as of 01:34, 28 September 2013
Home